| September 24-27, 2017 │ Kyoto, Japan Kyoto 2017 Congress, Expansion and Evolution of TDM and CT Plenary and Symposium Sessions |
|||
|
|
|||
| yyyy-mm-dd | Type | Link | Title and Presenters |
|
|
|||
| 2017-9-24 | IATDMCT-JSTDM Joint Symposium |  |
Recollections: the 1st CJSTDM & the 1st ICTDM Kazuhiko ‘Pico’ Tanaka |
|
|
|||
| 2017-9-24 | IATDMCT-JSTDM Joint Symposium | |
Overview of Clinical Toxicology Gwendolyn Appell McMillin |
|
|
|||
| 2017-9-24 | IATDMCT-JSTDM Joint Symposium | |
Improving clinical outcome using TDM Teun van Gelder |
|
|
|||
| 2017-9-24 | IATDMCT-JSTDM Joint Symposium | |
History of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology Steven H. Y. Wong |
|
|
|||
| 2017-9-24 | IATDMCT-JSTDM Joint Symposium | |
The role of the laboratory in optimizing anti-infective therapies in critically ill patients Pierre Wallemacq |
|
|
|||
| 2017-9-25 | Award Lecture 1 | |
Irving Sunshine Award Lecture Alain Verstraete |
|
|
|||
| 2017-9-24 | Joint Symposium | |
Liaison between IATDMCT and Members Denise Anne McKeown |
|
|
|||
| 2017-9-25 | Biomarkers and TDM of Immunosuppressive Drugs | |
Biomarkers in Solid Organ Transplantation: Prospects and Challenges Eberhard Wieland |
|
|
|||
| 2017-9-25 | Biomarkers and TDM of Immunosuppressive Drugs | |
Biomarkers and TDM of immunosuppressive drugs in kidney transplantation focus on pharmacogenetics Laure Elens |
|
|
|||
| 2017-9-25 | Biomarkers and TDM of Immunosuppressive Drugs | |
Determinants of intra-graft tacrolimus concentrations in renal transplant recipients Benedetta Sallustio |
|
|
|||
| 2017-9-25 | Biomarkers and TDM of Immunosuppressive Drugs | |
High intrapatient variability of tacrolimus exposure is associated with poorer outcomes after liver transplantation Camille Tron |
|
|
|||
| 2017-9-25 | TDM for multi-drug resistant organisms | |
Colistin: The PK, PD and TD Characteristics of this ‘Old’ Antibiotic Provide the Basis for TDM Roger Nation |
|
|
|||
| 2017-9-25 | TDM for multi-drug resistant organisms | |
Therapeutic Drug Monitoring of Beta-lactams Menino Osbert Cotta |
|
|
|||
| 2017-9-25 | YS Joint Symposium 2017 | |
Pharmacokinetics and therapeutic drug monitoring of monoclonal antibodies for inflammatory bowel diseases Sophie Berends |
|
|
|||
| 2017-9-25 | YS Joint Symposium 2017 | |
Bench-to-bedside research for the dermatological side effects induced by multiple tyrosine kinase inhibitors Kazuhiro Yamamoto |
|
|
|||
| 2017-9-25 | YS Joint Symposium 2017 | |
Therapeutic Drug Monitoring of Antiretrovirals: Applications in Management and Prevention Mark Marzinke |
|
|
|||
| 2017-9-26 | Plenary Lecture 2 | |
Why Use TDM and Dashboards for Monoclonal Antibodies? The Promise of Individualized Therapy Diane Renee Mould |
|
|
|||
| 2017-9-26 | Award Lecture 2 | |
C.E. Pippenger Award Lecture Christoph Hiemke |
|
|
|||
| 2017-9-27 | Award Lecture 4 | |
Patsalos Prize Lecture Michael Neely |
|
|
|||
IATDMCT, 4 Cataraqui Street Suite 310
Kingston, ON, K7K 1Z7, Canada
